Juan Jose Alegre-Sancho

11PUBLICATIONS
81CO-AUTHORS
AutoimmunityCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsRheumatology and arthritisApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Mar 05, 2026
The clinical phenotype of anti-Th/To+ patients in systemic sclerosis: a case-control study within the European Scleroderma Trials and Research cohort.

Liala Moschetti, Silvia Rovaris, Francesco Bonomi

|Nov 05, 2025
Anifrolumab in Systemic Lupus Erythematosus With Severe Hematological Manifestations: A Spanish Multicenter Study.

Adrián Mayo-Juanatey, Santos Castañeda, Vanesa Calvo-Río

|Oct 01, 2025
Anifrolumab in Systemic Lupus Erythematosus With Severe Hematological Manifestations: A Spanish Multicenter Study.

Adrián Mayo-Juanatey, Santos Castañeda, Vanesa Calvo-Río

|Dec 17, 2024
Real-World Clinical Effectiveness and Safety of Antifibrotics in Progressive Pulmonary Fibrosis Associated with Rheumatoid Arthritis.

Javier Narváez, Martí Aguilar-Coll, Vanesa Vicens-Zygmunt

|Nov 14, 2024
Oral Glucocorticoids for Skin Fibrosis in Early Diffuse Systemic Sclerosis: A Target Trial Emulation Study From the European Scleroderma Trials and Research Group Database.

Denis Mongin, Marco Matucci-Cerinic, Ulrich A Walker

|Jul 09, 2024
Correction: Rituximab in the treatment of progressive interstitial lung disease associated with the antisynthetase syndrome.

Javier Narvaez, Elena Canadillas, Ivan Castellvi

Pageof 2

Frequent Collaborators

3 joint publications

Iván Castellví

3 joint publications

Javier Narváez

2 joint publications

Adrián Mayo-Juanatey

2 joint publications

Marina Salido Olivares